Future Use of Novel Therapy in DLBCL

Considerations for using novel therapies such as polatuzumab vedotin-piiq in combination with bendamustine and rituximab in earlier treatment settings for diffuse large B-cell lymphoma, as well as other trials and drugs of interest.

For more resources and information regarding anticancer targeted therapies:

targeted oncology,oncology,cancer,